AUS
NZ
UK
CA
USA
IND
Healthcare
Anteris Technologies Strengthens Healthcare Position Across All Ordinaries Landscape
January 21, 2026 11:08 AM AEDT| By SamAnteris Technologies operates within the healthcare technology sector, delivering medical device innovation while maintaining representation within the All Ordinaries index.
Adheris Health Strengthens Digital Care Delivery Role Within All Ordinaries Healthcare Segment
January 21, 2026 10:49 AM AEDT| By SamAdheris Health delivers digital patient adherence and engagement services, reinforcing its role within the All Ordinaries healthcare technology segment.
Ansell Performance Insights Within the ASX 100 Landscape
January 20, 2026 06:20 PM AEDT| By SamObjective review of Ansell (ASX:ANN) highlights revenue stability, EPS decline, and dividend contributions, providing factual insights within the ASX 100 sector context.
ASX 50: Sonic Healthcare (ASX:SHL) Maintains Dividend Program
January 20, 2026 05:11 PM AEDT| By SamObjective review of Sonic Healthcare (ASX:SHL), detailing diagnostics operations, European expansion, dividend consistency, and market positioning within ASX 50 top companies.
Australia Stocks Close Lower as S&P/ASX 200 Reflects Broad ASX Market Movement
January 20, 2026 05:07 PM AEDT| By SamAustralian shares ended lower as the S&P/ASX 200 reflected broad sector movement, with materials, financials, and resource stocks shaping overall market activity.
Four D Medical (ASX:4DX) Shares Active, All Ordinaries Context
January 20, 2026 05:05 PM AEDT| By SamObjective overview of Four D Medical Limited highlighting healthcare technology operations, imaging solutions, distribution approach, and market context within the Australian equity landscape.
Healthcare Equipment Representation Across ASX 200 and ASX 100 Indices
January 20, 2026 04:27 PM AEDT| By SamHealthcare technology companies within the ASX 200 operate under regulated frameworks that integrate engineering, clinical collaboration, and global healthcare systems.
Nova Eye Medical (ASX:EYE) Shares Track ASX All Ordinaries
January 20, 2026 04:09 PM AEDT| By SamA factual look at Nova Eye Medical Limited, highlighting sector role, ophthalmic focus, and how broader market measures like the All Ordinaries provide contextual insight.
Illuccix Regulatory Progress Positions Telix Pharmaceuticals Across ASX 200 Landscape
January 20, 2026 02:09 PM AEDT| By SamTelix Pharmaceuticals records regulatory acceptance progress for Illuccix in China, reinforcing its international healthcare engagement within major ASX indices.
Digital Health Services Spotlight Cogstate Across All Ordinaries Index
January 20, 2026 12:27 PM AEDT| By SamCogstate operates within digital healthcare technology, delivering cognitive assessment platforms and maintaining participation within the All Ordinaries index of the Australian share market.
EBOS Steps Forward as ASX 200 Eyes Workforce Equity Shift
January 20, 2026 12:26 PM AEDT| By SamEBOS strengthens workforce alignment through a new employee share issuance, reflecting evolving governance practices and reinforcing its position within Australia’s established equity landscape.
Nova Eye Medical Clinical Technology Presence Within All Ordinaries Healthcare Space
January 20, 2026 12:16 PM AEDT| By SamNova Eye Medical delivers ophthalmic medical devices within the healthcare sector while maintaining representation inside the All Ordinaries index.
ASX 200 Spotlight: Why Mesoblast’s Clinical Progress Is Back in Focus
January 20, 2026 12:09 PM AEDT| By SamMesoblast’s renewed momentum highlights the growing role of regenerative medicine within the ASX landscape, driven by regulatory progress and long-term healthcare innovation.
ASX 100 Interest Rises as Telix Pharmaceuticals Advances Its Healthcare Innovation Strategy
January 20, 2026 11:48 AM AEDT| By SamTelix Pharmaceuticals strengthens its role within the medical-technology sector through radiopharmaceutical advances and expanding healthcare activity aligned with the ASX 100 landscape.
Lumos Diagnostics Clinical Collaboration Progress Within All Ordinaries Healthcare Landscape
January 19, 2026 07:31 PM AEDT| By SamLumos Diagnostics advances point-of-care testing development through clinical collaboration and regulatory coordination while maintaining representation within the All Ordinaries index.
Mesoblast Biotechnology Developments Within ASX 300 Healthcare Landscape
January 19, 2026 06:37 PM AEDT| By SamMesoblast operates within Australia’s biotechnology sector, advancing cellular medicine research while maintaining representation across the ASX 300 and ASX 200 indices.
Telix Pharma (ASX:TLX) Shares Fluctuate With ASX 200 Index Today
January 19, 2026 05:50 PM AEDT| By SamTelix Pharmaceuticals (ASX:TLX) operates in oncology radiopharmaceuticals, with ASX 200 sector positioning, financial metrics, and clinical development context shaping operational considerations.
Imricor Medical (ASX:IMR) Insider Sale Noted, All Ordinaries
January 19, 2026 04:47 PM AEDT| By SamAn objective overview of Imricor Medical Systems, examining insider activity, governance, and operational positioning within Australia’s medical devices sector.
Proteomics International Laboratories Diagnostic Expansion Across All Ordinaries Biotechnology Landscape
January 19, 2026 04:38 PM AEDT| By SamProteomics International Laboratories advances diagnostic research within Australia’s biotechnology sector while maintaining representation across the All Ordinaries index.
Elixinol Wellness Reshapes Sector Presence Across All Ordinaries Landscape
January 19, 2026 04:29 PM AEDT| By SamElixinol Wellness maintains visibility within the household-wellness sector through natural-health products and operational activity, aligning with broader trends across the All Ordinaries landscape.
Advertise your brand on Kalkine Media